Yatharth Hospital & Trauma Care Services Ltd (NSE: YATHARTH, BSE: 543950) is a Noida, Uttar Pradesh-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹10,047 Cr, it ranks #589 by market cap among the 6,197 Indian listed companies on FinBizNet, and #12 of 46 in Hospitals and Healthcare Centers. At ₹1,066.00 (as of 16 Nov 2026), the share price is 10.0% below its 52-week high of ₹1,184.00 and 98.0% above its 52-week low of ₹538.25. The share price is up 35.4% over one year and up 25.5% over three months.
| Current Price | ₹1,066.00 |
|---|---|
| Market Cap | ₹10,047 Cr |
| NSE Symbol | YATHARTH |
| BSE Code | 543950 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 58.3 |
| Return on Equity | 9.89% |
| Return on Assets | 6.39% |
| 52-Week Range | ₹538.25 – ₹1,184.00 |
| 1-Year Price Change | +35.4% |
| 3-Month Price Change | +25.5% |
| Beta (1Y) | 0.33 |
| Dividend Yield | 0.09% |
| Headquarters | Noida, Uttar Pradesh |
| Website | www.yatharthhospitals.com |
| Revenue | ₹431 Cr |
|---|---|
| Net Profit | ₹48 Cr |
| Net Margin | 11.2% |
| EPS (Basic) | ₹5.25 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Yatharth Hospital & Trauma Care Services Ltd reported revenue of ₹431 Cr in Q2 FY27, up 54.4% from ₹279 Cr in Q2 FY26 and up 9.9% from ₹393 Cr in Q1 FY27. It posted a net profit of ₹48 Cr for the quarter, against a net profit of ₹41 Cr in Q2 FY26 (up 17.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹232 Cr (Q4 FY25) to ₹431 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹431 Cr | ₹48 Cr | 11.2% |
| Q1 FY27 | ₹393 Cr | ₹45 Cr | 11.6% |
| Q4 FY26 | ₹342 Cr | ₹45 Cr | 13.1% |
| Q3 FY26 | ₹320 Cr | ₹43 Cr | 13.4% |
| Q2 FY26 | ₹279 Cr | ₹41 Cr | 14.8% |
| Q1 FY26 | ₹258 Cr | ₹42 Cr | 16.3% |
| Q4 FY25 | ₹232 Cr | ₹39 Cr | 16.7% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 55.80% of Yatharth Hospital & Trauma Care Services Ltd's shares as of Sept 2026, against 61.64% in Sept 2025 (−5.84 percentage points). Delivery averaged 38.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, neurology, neurosurgery, and cardiovascular and thoracic surgery. In addition, the company sells medicines and canteen food. The company was
1. Medical and Healthcare Services-This segment offers hospital services. 2. NA-NA 3. NA-NA 4. NA-NA
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Yatharth Hospital & Trauma Care Services Ltd | ₹10,047 Cr | 58.3 | 9.89% | ₹431 Cr | +35.4% |
Listed by market capitalisation. Ratios are shown for context only.
Yatharth Hospital & Trauma Care Services Ltd is trading at ₹1,066.00, with a market capitalisation of ₹10,047 Cr.
Yatharth Hospital & Trauma Care Services Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Yatharth Hospital & Trauma Care Services Ltd has a P/E of 58.3 and a return on equity of 9.89%.
Yatharth Hospital & Trauma Care Services Ltd is listed on the NSE under the symbol YATHARTH and on the BSE under the scrip code 543950.
Yatharth Hospital & Trauma Care Services Ltd's share price is up 35.4% over one year and up 25.5% over three months. Its 52-week range is ₹538.25 to ₹1,184.00.
In Q2 FY27, Yatharth Hospital & Trauma Care Services Ltd reported revenue of ₹431 Cr and net profit of ₹48 Cr, with basic EPS of ₹5.25 (consolidated, parsed from the company's exchange filing).
Yatharth Hospital & Trauma Care Services Ltd reported revenue of ₹431 Cr in Q2 FY27, up 54.4% from ₹279 Cr in Q2 FY26 and up 9.9% from ₹393 Cr in Q1 FY27.
Promoters held 55.80% of Yatharth Hospital & Trauma Care Services Ltd's shares as of Sept 2026, against 61.64% in Sept 2025 (−5.84 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.